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have been contradictory. The purpose of this study was to inves-
tigate lymphangiogenesis, angiogenesis and tumor tissue prolif-
erative activity depending on the clinical stages of melanoma.
The objects of the study were the samples of tumor tissue
obtained during surgical treatment of cutaneous malignant mel-
anoma. To analyze tumor angiogenesis, lymphangiogenesis and
proliferation, we performed immunostains of the primary mela-
nomas for the vascular marker CD34, for the lymphatic-specific
markers LYVE-1, D2 -40 (Podoplanin) and marker of proliferation
– Ki-67. Samples of tumor tissue from 40 patients with IA, IB,
IIA, IIB, IIIC melanoma stages were fixed in 10% neutral formalin,
processed by standard histological techniques and embedded in
paraffin. All steps of the immunohistochemical reaction were per-
formed by using BENCHMARK/XT slide stainer (Ventana).
Determination of blood vessel volume density revealed its
growth an average of 2 times in peritumoral areas. Similar data
were obtained about the location lymphatic vessels. Greater con-
tent peritumoral blood and lymphatic vessels, then intratumoral
could be detected in all stages of melanoma. In addition more sig-
nificantly greater volume density both intratumoral and peritu-
moral blood vessels, than lymphatic vessels was found. A
greater degree expression of endothelium lymphatic vessels
markers Podoplanin, compared with the LYVE-1 was shown. It
was noted an increasing volume density of the peritumoral blood
and lymphatic vessels in primary tumors with expansion clinical
stage melanoma. Three levels of proliferative activity of tumor
tissue were determined (low, an average degree and high Ki-67
expression). Results of the analysis have shown, that the high
proliferative activity corresponded to significant content of blood
and lymphatic vessels. High level of these markers was observed
in patients with regional lymph nodes metastases.
In recent years there have been appeared publications sug-
gesting that lymphatic vessel density (particularly in a peritu-
moral location) and lymphatic vessel invasion are predictors of
sentinel node metastasis and poorer survival. It was noted, that
‘‘larger, carefully conducted and well-reported studies that con-
firm these preliminary findings are required before it would be
appropriate to recommend the routine application of costly and
time-consuming immunohistochemistry for lymphatic markers
in the routine clinical assessment of primary cutaneous
melanomas”. In our opinion, one must consider not only the
lymphatic vessels density, but also blood vessels, and the tumor
tissue proliferative activity.
Conclusion: This study has shown that the complex markers of
lymphangiogenesis (Podoplanin), angiogenesis (CD34) and prolif-
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Background: Earlier we showed that at least some of nucleo-
tide sequences with tumor-specific expression are evolutionary
novel (reviewed in [A.P. Kozlov, 2014]). In this paper we per-
formed the study of the relative evolutionary novelty of human
oncogenes, all protein-coding genes, genes encoding tumor
antigens, tumor suppressors and tumor-associated genes using
homology searches in genomes of different taxa in human
lineage.
Materials and methods: The following databases were used as
a source of human genes: oncogenes – COSMIC (574 genes), tumor
suppressors – TSGene (636 genes), all tumor-associated genes –
allOnco (2116 genes) and NCG (2001 genes), cancer-testis (CT)
antigen genes – CTDatabase (276 genes) and all annotated human
protein coding genes – Genome assembly GRCh38 (21694 genes).
The list of cancer vaccine antigen genes was retrieved from paper
of Cheever et al., 2007, where 75 cancer antigens were ranked
according to their potential suitability for anticancer vaccines.
Some of cancer antigens are non-protein molecules, mutant or
fusion-proteins. Thus, we examined the evolutionary novelty of
only 58 protein-coding cancer vaccine antigen genes. To
analyze the evolutionary novelty of the explored genes the
HomoloGene release 68 tool and ProteinHistorian tool were
used. The HomoloGene tool searches the orthologs in 11 taxa of
the human lineage (Eukaryota, Opisthokonta, Bilateria,
Euteleostomi, Tetrapoda, Amniota, Boreoeutheria, Euarchon-
toglires Catarrhini, Homininae, H.sapiens) and the ProteinHisto-
rian tool searches the orthologs in 16 taxa of the human
ligeage (Cellular Organisms, Eukaryota, Opisthokonta, Bilateria,
Deuterostomia, Chordata, Euteleostomi, Tetrapoda, Amniota,
Mammalia, Theria, Eutheria, Euarchontoglires, Catarrhini,
Homininae, H.sapiens). To analyze the statistical significance of
data Fisher’s exact test was used.
Results: Several curves of taxonomic distribution of ortho-
logs of different classes of human genes have been generated.
A set of curves forms a peculiar picture where different curves
are organized in a definite order. The curves never intersect
after Bilateria. The uppermost position occupies the curve
which describes the oncogene orthologs distribution. Right
below the oncogene curve, the distribution curve of tumor
suppressor genes orthologs taxonomic is located, and the dif-
ference between these curves is significant. The distribution
curves of other tumor-associated genes orthologs overlap with
tumor suppressor curve. The medium position in the whole
picture is occupied by the distribution curve of orthologs of
all human protein-coding genes. Below this curve the distribu-
tion curves of orthologs of different tumor antigens are
located. The first below the medium curve is tumor vaccine
antigen curve, then CT and CT-X antigen genes orthologs
distribution curves are located. Thus at any given timepoint
the relative proportion of oncogene orthologs described by
distribution curve is higher than of any other studied class
of human genes.
Conclusion: 1. The evolution of human oncogenome advances
ahead of all other human gene classes. 2. On the other hand, the
evolution of tumor antigen gene classes goes behind the rest of
human gene classes, i.e. tumor antigens genome is more evolu-
tionary novel.
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